Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Recent preclinical studies have demonstrated that CLZ also possesses the ability to inhibit adenosine uptake by various cells, a property that distinguishes CLZ from other PDE3 inhibitors, such as milrinone.”
“In the present studies, cilostazol inhibited [3H]-adenosine uptake in both platelets and erythrocytes with a … 7 &mgr;M. Next collagen-induced platelet aggregation was studied and it was found that adenosine (1 &mgr;M), having … the IC50 of cilostazol from 2.66 &mgr;M …;M (p < 0.01).”
Journal of cardiovascular pharmacology • 2000 | View Paper
“ Cilostazol inhibits PDE III in platelets through an increase in adenosine 3 ́,5 ́-cyclic monophosphate (cAMP) content and activation of protein kinase A, resulting in antiplatelet aggregation.”
Journal of atherosclerosis and thrombosis • 2016 | View Paper
“Adding a low concentration of adenosine (0.3 microM) did not inhibit shear-induced platelet aggregation, but significantly enhanced the inhibitory effect of cilostazol in platelet-rich plasma.”
“ Cilostazol is classified as an antiplatelet agent because it inhibits the platelet aggregation induced by collagen, 5'-adenosine diphosphate ( ADP ), epinephrine, and arachidonic acid.”
“Papaverine, cilostazol , and rolipram also augmented both the magnitude and the duration of Isc following low dose stimulation of adenosine receptors with Ado (0.1-1.0 microM, P < 0.01).”
European journal of pharmacology • 2015 | View Paper
“ Cilostazol and draflazine increased the dialysate adenosine concentration during the first 10 min of muscle contraction, but had no effect during ischemia, most likely because of the high AMP deaminase activity in skeletal muscle.”
Circulation journal : official journal of the Japanese Circulation Society • 2010 | View Paper
“In the cerebral arterioles, low concentration (10–6M) of cilostazol or milrinone caused a significant shift of the dose-vasodilatory response curve for adenosine to the left.”